Avicanna Inc.

Symbol: TSX: AVCN OTCQX: AVCNF
Market Cap: 34M
Purpose Raise Awareness, Open Market Buying

Sector: Pharmaceutical
Summary:
  • Commercial stage biopharmaceutical company with 314% Y-Y growth in revenues in over 20+ countries
  • First pharmaceutical drug approval Q1 2024 for catastrophic epilepsy conditions
  • Extensive pipeline of pharmaceutical drugs addressing dermatological, neurological and pain disorders
  • Recently acquired medical cannabis by Shopper’s drug mart